Quidel Corporation

Quidel Corporation (Nasdaq: QDEL) is a California-based manufacturer of diagnostic healthcare solutions serving to enhance the health and well being of people around the globe through the development of diagnostic solutions that can lead to improved patient outcomes and provide economic benefits to the healthcare system.

Quidel is 35 years young, with commercialized products in the healthcare market since 1984. Originally known for lateral flow products used in physician’s offices, our product lines have expanded through robust product development to include tests in infectious disease and reproductive health that are used in hospitals, reference labs, and clinics as well. Our current products fall generally into these categories: (1) lateral flow, where we are market leaders in infectious disease and reproductive health; (2) direct fluorescent antibodies (DFA), with expertise in infectious disease and virology; (3) micro-titer production, with a focus on bone and complement pathway markets; (4) fluorescent immunoassay products (Sofia); and (4) molecular diagnostic products.

Whether at our headquarters in San Diego, California, at our research and manufacturing operations in Ohio, Massachusetts, and Germany, or through our Commercial organization around the world, the Company is delivering a continuum of diagnostic solutions from advanced lateral-flow and direct fluorescent antibody testing to molecular diagnostic tests that further improve the quality of healthcare.

Company Growth (employees)
San Diego, US
Size (employees)
627 (est)
Quidel Corporation was founded in 1979 and is headquartered in San Diego, US

Quidel Corporation Office Locations

Quidel Corporation has an office in San Diego
San Diego, US (HQ)
200 12544 High Bluff Dr

Quidel Corporation Data and Metrics

Quidel Corporation Financial Metrics

Quidel Corporation's revenue was reported to be $73.7 m in Q1, 2017

Revenue (Q1, 2017)

73.7 m

Gross profit (Q1, 2017)

50.1 m

Gross profit margin (Q1, 2017), %


Net income (Q1, 2017)

14.3 m

EBIT (Q1, 2017)

19.2 m

Market capitalization (22-Sep-2017)

1.4 b

Cash (31-Mar-2017)

197.5 m
Quidel Corporation's current market capitalization is $1.4 b.
USDFY, 2014FY, 2015FY, 2016


182.6 m196.1 m191.6 m

Revenue growth, %


Cost of goods sold

74.2 m71.7 m73.4 m

Gross profit

108.4 m124.4 m118.2 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017


31.5 m40.9 m61.3 m34.9 m46.8 m50.3 m39.1 m49.3 m73.7 m

Cost of goods sold

15.9 m16.8 m21.1 m15.5 m17 m19.2 m17.3 m17.7 m23.6 m

Gross profit

15.6 m24.1 m40.2 m19.4 m29.9 m31.1 m21.8 m31.6 m50.1 m

Gross profit Margin, %

USDFY, 2013FY, 2014FY, 2015FY, 2016


8.4 m200.9 m191.5 m169.5 m

Accounts Receivable

29.9 m34.5 m18.4 m25 m


27.6 m24.8 m26.4 m26 m

Current Assets

78.6 m275.1 m240.7 m225.4 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017


18.1 m17.4 m229.4 m204.7 m182.6 m153.4 m155.6 m153.4 m197.5 m

Accounts Receivable

17.2 m24.5 m18.7 m15.7 m31 m26.4 m16.2 m26.2 m20.9 m


23.5 m23.5 m22.9 m23.7 m24.6 m24.8 m23.1 m23.4 m22.5 m

Current Assets

72 m89.7 m285.3 m260.6 m251.1 m210 m200.2 m208.5 m244.9 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

7.4 m(7.1 m)(6.1 m)(13.8 m)

Accounts Receivable

2.9 m(4.5 m)16.1 m(6.3 m)


(12 m)2.9 m(1.6 m)859 k

Accounts Payable

(651 k)4.4 m(3.1 m)4.3 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(8.4 m)(14.2 m)4 m(4.9 m)(5.7 m)(3.4 m)(11.3 m)(11.9 m)14.3 m

Accounts Receivable

12.7 m5.5 m15.8 m18.8 m3.4 m(7.7 m)2.5 m(7.5 m)4 m


4.1 m4.1 m786 k1.1 m186 k2.1 m3.8 m3.5 m3.6 m

Accounts Payable

(1.4 m)(780 k)(3.2 m)(3.7 m)(1.9 m)1.2 m(1.9 m)984 k(4.3 m)
USDY, 2017


117.5 k

Financial Leverage

1.8 x
Show all financial metrics

Quidel Corporation Operating Metrics

FY, 2016


Show all operating metrics

Quidel Corporation Market Value History

Quidel Corporation Revenue Breakdown

Traffic Overview of Quidel Corporation

Quidel Corporation Company Life and Culture

You may also be interested in